Document Type
Article
Publication Title
Cureus
Abstract
Grover’s disease, also known as transient acantholytic dermatosis (TAD), currently has no published randomized control trials regarding the treatment of the disease; thus, evidence for treatment is largely derived from case studies and case reports. In this case series, we summarize the current treatment options for Grover’s disease and discuss two cases of refractory Grover’s disease treated with low-dose oral isotretinoin in patients who previously failed to reach clearance with multiple treatment options. Our aim is to highlight the efficacy of low-dose systemic retinoid therapy in Grover's disease when other treatment options prove unsatisfactory.
DOI
10.7759/cureus.53510
Publication Date
2-3-2024
Keywords
isotretinoin, acitretin, retinoids, Grover’s disease, transient acantholyitic dermatitis
ISSN
2168-8184
Recommended Citation
Moodie D, Dunn C, Fernandez C, Nathoo R. Retinoids for the Treatment of Refractory Grover’s Disease: A Case Series and Review of the Literature. Cureus. 2024; 16(2). doi: 10.7759/cureus.53510.
